Compounds of formula
as well as pharmaceutically acceptable salts and esters thereof, wherein R
1
to R
6
have the significance given in claim
1
can be used in the form of pharmaceutical compositions.
ALKIL-PYRIDINES AS 11-BETA INHIBITORS FOR DIABETES
申请人:F.HOFFMANN-LA ROCHE AG
公开号:EP1799647A1
公开(公告)日:2007-06-27
US7482341B2
申请人:——
公开号:US7482341B2
公开(公告)日:2009-01-27
[EN] ALKIL-PYRIDINES AS 11-BETA INHIBITORS FOR DIABETES<br/>[FR] ALKYL-PYRIDINES UTILISEES EN TANT QU'INHIBITEURS DE 11 BETA POUR LE TRAITEMENT DU DIABETE
申请人:HOFFMANN LA ROCHE
公开号:WO2006037501A1
公开(公告)日:2006-04-13
Compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
The present application provides antibiotic compounds, as well as pharmaceutical compositions comprising these compounds, and methods of treating bacterial infections using these compounds